psychedelics investing Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
psychedelics investing Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy
psychedelics investing Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition
psychedelics investing Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto
psychedelics investing Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia & Company
psychedelics investing Lobe Sciences Announces Additional Details Regarding the Acquisition of Altemia & Company
psychedelics investing Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia
Silver Hammer Prepares for Drill Program at Its 100% Owned California Patented Claim at The Eliza Project in Nevada
